sodium glycididazole
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
1
Earliest trial started Apr 1, 2008 (NCT00642239)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Studied for
Mechanism of action
- Serine-protein kinase ATMINHIBITOR
ATM inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
Cc1ncc([N+](=O)[O-])n1CCOC(=O)CN(CC(=O)[O-])CC(=O)OCCn1c([N+](=O)[O-])cnc1C.[Na+]- Mol. weight
- 519.4 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4297660 ↗
Also known as
- sodium glycididazole
- sodium glycididazole
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02721550 | Phase 2 | Sep 1, 2015 | Shandong University |
| NCT02721563 | Phase 2 | Sep 1, 2015 | Shandong University |
| NCT02721576 | Phase 2 | Sep 1, 2015 | Shandong University |
| NCT00642239 | Phase 4 | Apr 1, 2008 | Chinese Academy of Medical Sciences, Luye Pharma |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shandong University | Academic/Hospital | 3 | 3 | 1 | 2015 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Luye Pharma | For profit | 1 | 1 | 1 | 2008 |
3 organizations
Page 1 / 1